Owner and principal consultant
HMC-regulation
Aseret, HaDarom, Israel
Hagit is a seasoned regulatory affairs and drug development executive with a robust scientific background and over 20 years of experience in the biotech, pharmaceutical, and combination product industries. Her expertise spans the entire spectrum of drug development, from early-stage research to post-marketing approval.
Hagit has extensive experience in nonclinical and clinical studies, GMP and CMC requirements, and managing meetings with Health Authorities (HAs). She is adept at preparing and submitting regulatory documents to the FDA, EMA, and other global Health Authorities. Her skills include developing regulatory and drug development strategies, conducting gap analyses, and compiling complete registration files.
Currently, Hagit leverages her vast experience as an independent consultant, providing regulatory consultation services to companies, bio-med incubators, and venture capital firms. She offers her expertise either on a permanent basis, leading regulatory affairs activities, or on specific projects.
Solutions Circle 2: Reliance That Delivers: From WHO Good Reliance Practices to Project Orbis
Wednesday, May 6, 2026
13:50 - 14:20 WEST
Solutions Circle 4: Reliance That Delivers: From WHO Good Reliance Practices to Project Orbis
Thursday, May 7, 2026
09:40 - 10:10 WEST
Conditional Approval and Expedited Pathways: EU and US Regulatory Strategies
Thursday, May 7, 2026
12:00 - 13:00 WEST